G62
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study will include patients with chronic pain who are already being treated regularly and successfully with topical capsaicin. No vulnerable groups will be included. The affected pain areas should be located in the extremities or the trunk.
Exclusion criteria
Exclusion criteria: Patients with known skin conditions presenting with current skin manifestations or skin injuries in the measurement areas will be excluded. Patients with pain in the trigeminal region will also be excluded, as no control data from healthy subjects are available for the facial tests. Patients will be excluded if, due to a language barrier, the study briefing or the assessment of pain intensity cannot be conducted in German or English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the normalized pain rating during the 60-second 4-Hz stimulation in the pain area versus the control skin area before capsaicin (increase rather than adaptation) and the change in this rating one week after treatment. Additionally, the difference between the sums of pain ratings for half-sine stimuli (polymodal nociceptors only) and for 4-Hz sine stimuli (polymodal + silent nociceptors) in the pain area compared to the control skin before and after capsaicin. Subjective pain perception is assessed and analyzed using the Numerical Rating Scale (NRS). This is measured at three time points (T1 = before capsaicin application, T2 = T1 + one week, T3 = T1 + three months). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint is the correlation between the reduction in spontaneous pain and the reduction in measured hypersensitivity of C-nociceptors. | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie des Universitätsklinikums Heidelberg, Sektion Schmerzmedizin